Official says supply will be halved in first quarter of 2021 due to production problems
AstraZeneca is to cut deliveries of its Covid-19 vaccine to the EU by 60% in the first quarter of the year due to production problems, a senior official has told Reuters.
The jab it developed with the University of Oxford is already in widespread use in the UK, but the European Union has not yet approved it. It is expected to make a decision by January 29.
